Bridging life science
innovation and
global capital.

A healthcare-focused fund and cross-border advisor connecting innovators in China, the United States and Europe with investors and strategic partners.

See our track record Get in touch

Pharmaceuticals · Diagnostics · Medical Devices

Founded: 2013
Countries invested or served: 14
Portfolio exits: 8
Companies backed or advised: 50+

IWho we are

Scientists and investors, side by side.

Lynx Financial is a healthcare and life science focused fund and cross-border advisor, investing in innovative technologies for the benefit of patients around the world. We are physicians, scientists, entrepreneurs, consultants and investment professionals who share a common goal: getting important medical innovation to the patients who need it.

Founded in 2013, with offices in Shanghai and San Diego and a European office in preparation.

Meet the partners How we run a transaction

Inbound Advisory
Bringing overseas innovation into China.
Strategic partnerships, joint ventures, product licensing and equity investment that help international companies fill gaps in the Chinese market and capture first-mover advantage.
Equity Investment
Seed to Series A.
Direct investment in early-stage innovators across drugs, medical devices and diagnostics, alongside active support through every subsequent round.
Outbound Advisory
Taking Chinese innovation global.
Out-licensing and NewCo structures that position Chinese technologies for global R&D and accelerate the return of capital.

IISector focus

Deep coverage across life sciences.

Our partners combine medical and scientific training with investment experience, so we can assess the technology as well as the deal.

Pharmaceuticals

Oncology, cardiovascular, diabetes, viral hepatitis, NASH, CNS, wound care, orthopaedics, aesthetics, anti-infectives, ophthalmology, HIV, antiviral vaccines, pain, paediatrics and rare diseases.

Diagnostics

Pre-operative cancer diagnostics and intra-operative imaging (optical, electrical, MRI), gene sequencing, liquid biopsy, point-of-care molecular pathogen testing, non-invasive glucose monitoring and dental imaging.

III

Medical Devices

Heart and venous valves, vascular grafts, implantable cardioverter-defibrillators, glucose meters, ultrasonic scalpels, joint replacements, renal denervation, haemostatic and novel biomaterials, resorbable vena cava filters, bowel preparation and surgical instruments.

What we look for in an investment

IIITrack record